News

Podcast

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Kevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com